Clinical evaluation of siddha drug Ponnavarai choornam (internal) in the treatment of Tinea versicolor(Themal)

Clinical evaluation of siddha drug Ponnavarai choornam in the treatment of Themal(Tinea versicolor)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008026

Enrollment

Registered

2017-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- THEMAL (TENIA VERSICOLOR)

Interventions

Intervention1: Ponnavarai choornam (internal): 1 gm of Ponnavarai choornam administered orally twice a day with honey for a period of 48 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: o Typical hypo pigmented or hyperpigmented macules, plaques or sheets distribution on the neck or upper part of the trunk or upper part of the arm or forehead or cheeks. o Branny scaling o Willing to sign the informed consent. Willing to give blood and urine sample for laboratory investigations

Exclusion criteria

Exclusion criteria: o Lesions with secondary infections o Any other systemic diseases o VDRL Positive cases o Diabetes mellitus o Hypertension o Use of narcotic drugs.

Design outcomes

Primary

Measure	Time frame
Reduction of size and number of patches & clinical symptoms like Itching, Scaling and the skin resumes normal complexion.Timepoint: 48 days	—

Secondary

Measure	Time frame
1. To study the effect of other associated factors like age, sex and site of lesionTimepoint: 48 days	—

Countries

India

Contacts

Public ContactDr Lakshmikantham R

National Institute of Siddha

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026